ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Franklin Global Growth Fund

Franklin Global Growth Fund (FGGE)

25.78
-0.04
(-0.15%)
Closed January 06 4:12PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
25.78
Bid
25.62
Ask
25.99
Volume
174
25.85 Day's Range 25.85
0.00 52 Week Range 0.00
Previous Close
25.82
Open
25.85
Last Trade
74
@
25.85
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FGGE Latest News

Franklin Templeton Canada annonce les distributions en espèces définitives de décembre et les distributions annuelles définitives réinvesties pour les FNB

Franklin Templeton Canada annonce les distributions en espèces définitives de décembre et les distributions annuelles définitives réinvesties pour les FNB Canada...

Franklin Templeton Canada annonce les distributions en espèces de décembre et les distributions annuelles réinvesties estimatives pour les FNB

Franklin Templeton Canada annonce les distributions en espèces de décembre et les distributions annuelles réinvesties estimatives pour les FNB Canada NewsWire TORONTO, le 20...

Franklin Templeton Canada annonce les distributions en espèces et les distributions annuelles réinvesties estimées pour certains FNB

Franklin Templeton Canada annonce les distributions en espèces et les distributions annuelles réinvesties estimées pour certains FNB Canada NewsWire TORONTO, le 22 nov. 2024...

Franklin Templeton Canada annonce les distributions en espèces définitives de décembre et les distributions annuelles définitives réinvesties pour les FNB

Franklin Templeton Canada annonce les distributions en espèces définitives de décembre et les distributions annuelles définitives réinvesties pour les FNB Canada...

Franklin Templeton Canada Announces Estimated December ETF Cash Distributions and Annual Reinvested Distributions

Franklin Templeton Canada Announces Estimated December ETF Cash Distributions and Annual Reinvested Distributions Canada NewsWire TORONTO, Dec. 19, 2023 TORONTO, Dec. 19, 2023 /CNW/ - Franklin...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSAIMultiSensor AI Holdings Inc
$ 2.80
(40.00%)
2.54M
MCVTMill City Ventures III Ltd
$ 3.0201
(33.63%)
98.63k
XTIAXTI Aerospace Inc
$ 0.1167
(32.61%)
367.95M
QRTEBQurate Retail Inc
$ 3.13
(22.27%)
103
NARIInari Medical Inc
$ 78.87
(21.34%)
4.7M
ENVBEnveric Biosciences Inc
$ 0.34
(-19.53%)
433.75k
GDTCCytoMed Therapeutics Ltd
$ 2.86
(-16.62%)
63.14k
AMSTAmesite Inc
$ 3.45
(-14.81%)
60.65k
SLRNACELYRIN Inc
$ 2.9799
(-14.62%)
506.18k
ACXPAcurx Pharmaceuticals Inc
$ 0.9401
(-13.75%)
166.45k
XTIAXTI Aerospace Inc
$ 0.1167
(32.61%)
367.95M
SVMHSRIVARU Holding Ltd
$ 0.0512
(10.58%)
29.93M
CRKNCrown Electrokinetics Corporation
$ 0.145
(9.02%)
27.07M
CEROCERo Therapeutics Holdings Inc
$ 0.0468
(10.64%)
18.45M
CDTConduit Pharmaceuticals Inc
$ 0.082
(13.42%)
16.67M

Discussion

View Full Feed
mikepgator mikepgator 45 seconds ago
That video got 42K views in the last couple days. It could be the reason for some of the volume today, new investors taking a position at a great time.
RDGL
LocWolf LocWolf 47 seconds ago
Dr. Dent will need to push the AI metabolic testing deep into genes and blood tests. If he can establish this it will be another driver for HLYK. All this pushes deep into preventative areas of disease in order to strive towards "Forever Young" ...etc
HLYK
DewDiligence DewDiligence 1 minute ago
From SLRN’s press release:

https://www.globenewswire.com/news-release/2025/01/06/3004952/0/en/ACELYRIN-INC-Announces-Additional-Phase-2-Data-and-Phase-3-Program-Design-for-Lonigutamab-in-Thyroid-Eye-Disease.html In the newly announced data from the ongoing Phase 2 trial in TED, lonig
ENTA
indyterp indyterp 2 minutes ago
DB;  You are absolutely correct.  Big news should be coming soon, and our long wait will have been worthwhile!

Bullish
VPLM
Elroy Jetson Elroy Jetson 3 minutes ago
What do you like about Schwab in comparison with Fidelity?
ron_66271 ron_66271 3 minutes ago
RSI(14) 74.77.

https://stockcharts.com/h-sc/ui?s=fnma



Ron
FNMA
JAB65 JAB65 3 minutes ago
Happy New Year plus seven!
This is the year, one way or the other!!!
$TGLO
TGLO
jmhgolf jmhgolf 4 minutes ago
It's an exchange to trade crypto?  There must be a Drgv coin? Why would they list an OTC ticker on crypto exchange?
DRGV
habib7 habib7 4 minutes ago
I don't understand all the hate/attacks on this board. You want just rah-rah cheerleaders? Or should you balance all perspectives?

Back of napkin FNMA valuation for me...
15B net income x 10x multiple = 150B market cap
150B / 1.15b outstanding shares = $125.5 per shar
FNMAS
LexTrader LexTrader 4 minutes ago
Try some horse paste 🙂
judypudy judypudy 4 minutes ago
Check out this link for an update from the owner of EESO. https://x.com/Icestormmarket
EESO
Halkid Halkid 4 minutes ago
Lol
BLFR
HokieHead HokieHead 4 minutes ago
I stated a ticker that was halted the same time as TWOH just released news this afternoon.

Once PRs start this is going to get crazy.
TWOH
northam43 northam43 4 minutes ago
Report #2 January 2025 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2025/1/6/uzpcu2_Completed_Cycles.PNG
zakattack zakattack 5 minutes ago
So we were lied to and scammed great another otc pos aholes
UBQU
La Flaca La Flaca 6 minutes ago
Alot hinges on EMA approval so it makes sense that Anavex is positioning itself for maximum visibility with journal articles, presentations, OLE data presentation. The drug seems to be effective if taken early enough. I hope this is top of mind during EMA approval process. That's the bottom line - t
AVXL
TheKid5 TheKid5 6 minutes ago
$0.00000000000000000000000
TPTW
dia76ca dia76ca 6 minutes ago
PRIORITY REVIEW (FDA)
"Prior to approval, each drug marketed in the United States must go through a detailed FDA review process. In 1992, under the Prescription Drug User Act (PDUFA), FDA agreed to specific goals for improving the drug review time and created a two-tiered system of review tim
AVXL
Threes Threes 6 minutes ago
They probably had buyers in Ampersand in the waiting. Nick getting his ill gotten gains while they consolidate the shares.
CDMO
ThunderousSeer8 ThunderousSeer8 6 minutes ago
There's a lot of human behavior and psychology in investing. I think they can't understand what it's even like to be a person that has a sustainable future regardless of how this turns out. Their perspectives are so limited and their ability to analyze themselves is lacking. I wish you all the best
RDAR
flipper44 flipper44 6 minutes ago
I think the short positions that bought warrants with their initial proceeds, can cover their short shares by exercising an equal number of warrants at a fixed low price. There are 47 million legal short shares, some of which may be hedged with warrants.

I don’t know enough about t
NWBO
DrivenByPain DrivenByPain 8 minutes ago
SGDH Security Details Updated Today No Change 01/06/2025 https://www.otcmarkets.com/stock/SGDH/security
SGDH
ergo sum ergo sum 8 minutes ago
The democrats gave away the election and now like to pretend how polite they are surrendering power.
looking 4 a win looking 4 a win 8 minutes ago
Great question, pigs don't always get slaughtered. Sometimes they go on to become pig kings! 
Anyway, also- foubl?
BB

Your Recent History

Delayed Upgrade Clock